Compare Citigroup Inc. (C) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citigroup Inc. vs Recursion Pharmaceuticals Inc — how do they compare? Citigroup Inc. trades at $134.3 (market cap $239.99B), while Recursion Pharmaceuticals Inc trades at $3.38 (market cap $1.75B). The key difference: Citigroup Inc. is far larger — about 137.1× Recursion Pharmaceuticals Inc's market cap, and Citigroup Inc. pays a 1.71% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| C | RXRX | |
|---|---|---|
Market Cap | $239.99B | $1.75B |
Sector | Financials | Health |
52-Week High | $145.67 | $6.79 |
52-Week Low | $90.02 | $2.84 |
Dividend Yield | 1.71% | — |
Enterprise Value | — | $1.17B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citigroup Inc.
Citigroup Inc. is a diversified financial services holding company that provides a broad range of financial services to consumer and corporate customers. The Company services include investment banking, retail brokerage, corporate banking, and cash management products and services. Citigroup serves customers globally.
Read more on C →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
